-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GQY0vDnFCM9T3R+qb9KdVZE0FvFbjNsS1LkNac+S/lHjpz536k7FCyX+pzMH7HKd YwSj2TuzhLPJbZYvlo6pMQ== 0000950135-00-000571.txt : 20000211 0000950135-00-000571.hdr.sgml : 20000211 ACCESSION NUMBER: 0000950135-00-000571 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INVITROGEN CORP CENTRAL INDEX KEY: 0001073431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330373077 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-56717 FILM NUMBER: 530358 BUSINESS ADDRESS: STREET 1: 1600 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7606037200 MAIL ADDRESS: STREET 1: 1600 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CHARPIE RICHARD A CENTRAL INDEX KEY: 0001054509 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O AMPERSAND VENTURES STREET 2: 55 WILLIAM STREET SUITE 240 CITY: WELLESLEY STATE: MA ZIP: 02181 BUSINESS PHONE: 8002390706 MAIL ADDRESS: STREET 1: C/O AMPERSAND VENTURES STREET 2: 55 WILLIAM STREET SUITE 240 CITY: WELLESLEY STATE: MA ZIP: 02181 SC 13G/A 1 RICHARD A. CHARPIE 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (AMENDMENT NO. 1)* INVITROGEN CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 46185R 10 0 (CUSIP Number) 12/31/99 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - -------------------- * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 SCHEDULE 13G/A - ---------------------- ----------------- CUSIP NO. 46185R 10 0 PAGE 2 OF 6 PAGES - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Richard A. Charpie - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] Not Applicable (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 0 shares SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ------------------------------------------------------ 6 SHARED VOTING POWER 223,901 shares ------------------------------------------------------ 7 SOLE DISPOSITIVE POWER 0 shares ------------------------------------------------------ 8 SHARED DISPOSITIVE POWER 223,901 shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 223,901 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.2% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- 3 SCHEDULE 13G/A - ---------------------- ----------------- CUSIP NO. 46185R 10 0 PAGE 3 OF 6 PAGES - -------------------------------------------------------------------------------- ITEM 1(a). NAME OF ISSUER: Invitrogen Corporation ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 1600 Faraday Avenue Carlsbad, CA 92008 ITEM 2(a). NAME OF PERSON FILING: Richard A. Charpie ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: c/o Ampersand Ventures 55 William Street, Suite 240 Wellesley, MA 02481-4003 ITEM 2(c). CITIZENSHIP: Richard A. Charpie is a citizen of the United States of America ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $0.01 par value ITEM 2(e). CUSIP NUMBER: 46185R 10 0 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: Not Applicable 4 SCHEDULE 13G/A - ---------------------- ----------------- CUSIP NO. 46185R 10 0 PAGE 4 OF 6 PAGES - -------------------------------------------------------------------------------- ITEM 4. OWNERSHIP. (a) Amount beneficially owned: Richard A. Charpie may be attributed with the ownership of 167,927 shares held by Ampersand Specialty Materials and Chemicals II Limited Partnership, 41,981 shares held by Laboratory Partners I Limited Partnership and 13,993 shares held by Laboratory Partners Companion Fund Limited Partnership. Dr. Charpie is the Managing Partner of ASMC-II MCLP LLP and Ampersand Lab Partners MCLP LLP. ASMC-II MCLP LLP is the General Partner of ASMC-II Management Company Limited Partnership, which is the General Partner of Ampersand Specialty Materials and Chemicals II Limited Partnership. Ampersand Lab Partners MCLP LLP is the General Partner of Ampersand Lab Partners Management Company Limited Partnership, which is the General Partner of Laboratory Partners I Limited Partnership and Laboratory Partners Companion Fund Limited Partnership. Dr. Charpie disclaims beneficial ownership of all shares except to the extent of his proportionate pecuniary interest therein. (b) Percent of class: Richard A. Charpie 1.2% (c) Number of shares as to which such person has: (i) Sole power to vote or direct the vote: None (ii) Shared power to vote or direct the vote: Richard A. Charpie shares voting power over 167,927 shares held by Ampersand Specialty Materials and Chemicals II Limited Partnership, 41,981 shares held by Laboratory Partners I Limited Partnership and 13,993 shares held by Laboratory Partners Companion Fund Limited Partnership. (iii) Sole power to dispose or to direct the disposition of: None (iv) Shared power to dispose or to direct the disposition of: Richard A. Charpie shares dispositive power over 167,927 shares held by Ampersand Specialty Materials and Chemicals II Limited Partnership, 41,981 shares held by Laboratory Partners I Limited Partnership and 13,993 shares held by Laboratory Partners Companion Fund Limited Partnership. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of Securities, check the following [X]. 5 SCHEDULE 13G/A - ---------------------- ----------------- CUSIP NO. 46185R 10 0 PAGE 5 OF 6 PAGES - -------------------------------------------------------------------------------- ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not Applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not Applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not Applicable ITEM 10. CERTIFICATION. Not Applicable 6 SCHEDULE 13G/A - ---------------------- ----------------- CUSIP NO. 46185R 10 0 PAGE 6 OF 6 PAGES - -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 9, 2000 By: /s/ Richard A. Charpie --------------------------------- Richard A. Charpie -----END PRIVACY-ENHANCED MESSAGE-----